Literature DB >> 21525011

Involvement of Jun dimerization protein 2 (JDP2) in the maintenance of Epstein-Barr virus latency.

Takayuki Murata1, Chieko Noda, Shinichi Saito, Daisuke Kawashima, Atsuko Sugimoto, Hiroki Isomura, Teru Kanda, Kazunari K Yokoyama, Tatsuya Tsurumi.   

Abstract

Reactivation of the Epstein-Barr virus from latency is dependent on expression of the BZLF1 viral immediate-early protein. The BZLF1 promoter (Zp) normally exhibits only low basal activity but is activated in response to chemical inducers such as 12-O-tetradecanoylphorbol-13-acetate and calcium ionophore. We found that Jun dimerization protein 2 (JDP2) plays a significant role in suppressing Zp activity. Reporter, EMSA, and ChIP assays of a Zp mutant virus revealed JDP2 association with Zp at the ZII cis-element, a binding site for CREB/ATF/AP-1. Suppression of Zp activity by JDP2 correlated with HDAC3 association and reduced levels of histone acetylation. Although introduction of point mutations into the ZII element of the viral genome did not increase the level of BZLF1 production, silencing of endogenous JDP2 gene expression by RNA interference increased the levels of viral early gene products and viral DNA replication. These results indicate that JDP2 plays a role as a repressor of Zp and that its replacement by CREB/ATF/AP-1 at ZII is crucial to triggering reactivation from latency to lytic replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21525011      PMCID: PMC3121345          DOI: 10.1074/jbc.M110.199836

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.

Authors:  Amy L Ellis; Zhenxun Wang; Xianming Yu; Janet E Mertz
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

2.  Tetrameric ring formation of Epstein-Barr virus polymerase processivity factor is crucial for viral replication.

Authors:  Sanae Nakayama; Takayuki Murata; Yoshihiro Yasui; Kazutaka Murayama; Hiroki Isomura; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

3.  Efficient production of infectious viruses requires enzymatic activity of Epstein-Barr virus protein kinase.

Authors:  Takayuki Murata; Hiroki Isomura; Yoriko Yamashita; Shigenori Toyama; Yoshitaka Sato; Sanae Nakayama; Ayumi Kudoh; Satoko Iwahori; Teru Kanda; Tatsuya Tsurumi
Journal:  Virology       Date:  2009-05-08       Impact factor: 3.616

4.  The AP-1 repressor protein, JDP2, potentiates hepatocellular carcinoma in mice.

Authors:  Keren Bitton-Worms; Eli Pikarsky; Ami Aronheim
Journal:  Mol Cancer       Date:  2010-03-09       Impact factor: 27.401

5.  Transcriptional repression by sumoylation of Epstein-Barr virus BZLF1 protein correlates with association of histone deacetylase.

Authors:  Takayuki Murata; Naoe Hotta; Shigenori Toyama; Sanae Nakayama; Shigeki Chiba; Hiroki Isomura; Takayuki Ohshima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2010-06-01       Impact factor: 5.157

6.  JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence.

Authors:  Koji Nakade; Jianzhi Pan; Takahito Yamasaki; Takehide Murata; Bohdan Wasylyk; Kazunari K Yokoyama
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

7.  JDP2 suppresses adipocyte differentiation by regulating histone acetylation.

Authors:  K Nakade; J Pan; A Yoshiki; H Ugai; M Kimura; B Liu; H Li; Y Obata; M Iwama; S Itohara; T Murata; K K Yokoyama
Journal:  Cell Death Differ       Date:  2007-04-20       Impact factor: 15.828

8.  ZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells.

Authors:  Wen-hai Feng; Richard J Kraus; Sarah J Dickerson; Hui Jun Lim; Richard J Jones; Xianming Yu; Janet E Mertz; Shannon C Kenney
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

9.  TORC2, a coactivator of cAMP-response element-binding protein, promotes Epstein-Barr virus reactivation from latency through interaction with viral BZLF1 protein.

Authors:  Takayuki Murata; Yoshitaka Sato; Sanae Nakayama; Ayumi Kudoh; Satoko Iwahori; Hiroki Isomura; Masako Tajima; Takayuki Hishiki; Takayuki Ohshima; Makoto Hijikata; Kunitada Shimotohno; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

10.  TRE-dependent transcription activation by JDP2-CHOP10 association.

Authors:  Keren Weidenfeld-Baranboim; Keren Bitton-Worms; Ami Aronheim
Journal:  Nucleic Acids Res       Date:  2008-05-07       Impact factor: 16.971

View more
  10 in total

1.  Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.

Authors:  Chieko Noda; Takayuki Murata; Teru Kanda; Hironori Yoshiyama; Atsuko Sugimoto; Daisuke Kawashima; Shinichi Saito; Hiroki Isomura; Tatsuya Tsurumi
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

2.  Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Authors:  Takayuki Murata; Yohei Narita; Atsuko Sugimoto; Daisuke Kawashima; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2013-07-10       Impact factor: 5.103

3.  Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome.

Authors:  Sharada Ramasubramanyan; Kay Osborn; Kirsty Flower; Alison J Sinclair
Journal:  J Virol       Date:  2011-11-16       Impact factor: 5.103

4.  Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.

Authors:  Takayuki Murata; Yutaka Kondo; Atsuko Sugimoto; Daisuke Kawashima; Shinichi Saito; Hiroki Isomura; Teru Kanda; Tatsuya Tsurumi
Journal:  J Virol       Date:  2012-02-22       Impact factor: 5.103

Review 5.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

6.  Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor.

Authors:  Takayuki Murata; Chieko Noda; Yohei Narita; Takahiro Watanabe; Masahiro Yoshida; Keiji Ashio; Yoshitaka Sato; Fumi Goshima; Teru Kanda; Hironori Yoshiyama; Tatsuya Tsurumi; Hiroshi Kimura
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

7.  Jun Dimerization Protein 2 Activates Mc2r Transcriptional Activity: Role of Phosphorylation and SUMOylation.

Authors:  Chiung-Min Wang; Raymond X Wang; Runhua Liu; Wei-Hsiung Yang
Journal:  Int J Mol Sci       Date:  2017-01-31       Impact factor: 5.923

8.  Phospho-proteomics identifies a critical role of ATF2 in pseudorabies virus replication.

Authors:  Fang-Fang Jiang; Ren-Qi Wang; Chao-Yue Guo; Ke Zheng; Hai-Long Liu; Le Su; Sheng-Song Xie; Huan-Chun Chen; Zheng-Fei Liu
Journal:  Virol Sin       Date:  2022-06-07       Impact factor: 6.947

9.  Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency.

Authors:  Takayuki Murata; Tatsuya Tsurumi
Journal:  Front Genet       Date:  2013-04-09       Impact factor: 4.599

10.  Andrographolide Inhibits Lytic Reactivation of Epstein-Barr Virus by Modulating Transcription Factors in Gastric Cancer.

Authors:  Praphatson Malat; Tipaya Ekalaksananan; Chukkris Heawchaiyaphum; Supawadee Suebsasana; Sittiruk Roytrakul; Yodying Yingchutrakul; Chamsai Pientong
Journal:  Microorganisms       Date:  2021-12-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.